ArticleBMC geriatrics2025

Long-term prostate cancer survival outcomes including patterns of death in men >=75 years of age treated with low dose rate brachytherapy.

Shalini Moningi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.